[A case of RAEB (refractory anemia with excess of blast) in transformation in childhood].
Acute megakaryoblastic leukemia preceded by refractory anemia with an excess of blast cells: leukemic transformation in an infant of Down syndrome recovering from transient abnormal myelopoiesis.
Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U.
Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5.
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.
Leuk Res. 2016 Jun;45:82-9. doi: 10.1016/j.leukres.2016.04.003. Epub 2016 Apr 11.
Trisomy 14 in refractory anemia with excess of blasts in transformation.
Haas OA, Jäger U, Ambros P, Pabinger I.
Cancer Genet Cytogenet. 1987 Dec;29(2):315-8. doi: 10.1016/0165-4608(87)90242-1.
Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.
Michels SD, Saumur J, Arthur DC, Robison LL, Brunning RD.
Cancer. 1989 Dec 1;64(11):2340-6. doi: 10.1002/1097-0142(19891201)64:11<2340::aid-cncr2820641125>3.0.co;2-i.
Re-evaluation of refractory anemia with excess blasts in transformation.
Ohyashiki K, Nishimaki J, Shoji N, Miyazawa K, Kimura Y, Ohyashiki JH.
Leuk Res. 2001 Nov;25(11):933-9. doi: 10.1016/s0145-2126(01)00054-6.
Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients.
Smadja N, Krulik M, de Gramont A, Gonzalez-Canali G, Audebert AA, Debray J.
Cancer Genet Cytogenet. 1989 Oct 1;42(1):55-65. doi: 10.1016/0165-4608(89)90008-3.
Allogeneic bone marrow transplantation for myelodysplastic syndromes of childhood: report of three children with refractory anemia with excess of blasts in transformation and review of the literature.
Uderzo C, Locasciulli A, Rajnoldi AC, Mozzana R, Lambertenghi-Deliliers G, Masera G.
Med Pediatr Oncol. 1993;21(1):43-8. doi: 10.1002/mpo.2950210109.
The myelodysplastic syndromes.
Masey JA.
Br J Biomed Sci. 1997 Mar;54(1):65-70.
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
Becker H, Suciu S, Rüter BH, Platzbecker U, Giagounidis A, Selleslag D, Labar B, Germing U, Salih HR, Muus P, Pflüger KH, Hagemeijer A, Schaefer HE, Fiaccadori V, Baron F, Ganser A, Aul C, de Witte T, Wijermans PW, Lübbert M.
Ann Hematol. 2015 Dec;94(12):2003-13. doi: 10.1007/s00277-015-2489-6. Epub 2015 Sep 24.
Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, Nakahata T, Manabe A; Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group.
Br J Haematol. 2012 Sep;158(5):657-61. doi: 10.1111/j.1365-2141.2012.09210.x. Epub 2012 Jun 26.
